JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $78,000 | -35.0% | 11,484 | -20.3% | 0.00% | – |
| Q4 2021 | $120,000 | +6.2% | 14,417 | -5.0% | 0.00% | – |
| Q3 2021 | $113,000 | -6.6% | 15,170 | -14.6% | 0.00% | – |
| Q2 2021 | $121,000 | +8.0% | 17,754 | +63.3% | 0.00% | – |
| Q1 2021 | $112,000 | +13.1% | 10,872 | -28.6% | 0.00% | -100.0% |
| Q3 2018 | $99,000 | -17.5% | 15,233 | -3.2% | 0.00% | 0.0% |
| Q2 2018 | $120,000 | -68.0% | 15,729 | -6.1% | 0.00% | -50.0% |
| Q1 2018 | $375,000 | +50.6% | 16,759 | -14.1% | 0.00% | 0.0% |
| Q4 2017 | $249,000 | – | 19,521 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|